Log rank test analyses showed a significant association between the elevated UCP1 (Fig. 1C-E) mRNA levels and improved OS, post-progression survival (PPS), and progression-free survival (PFS) (p < 0.05) of all ovarian cancer patients. This evidence concerns the gene UCP1 and ovarian cancer.